RCSB PDB - 4LRG: Structure of BRD4 bromodomain 1 with a dimethyl thiophene isoxazole azepine carboxamide (original) (raw)
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
[Gehling, V.S.](/search?q=citation.rcsb%5Fauthors:Gehling, V.S.), [Hewitt, M.C.](/search?q=citation.rcsb%5Fauthors:Hewitt, M.C.), [Vaswani, R.G.](/search?q=citation.rcsb%5Fauthors:Vaswani, R.G.), [Leblanc, Y.](/search?q=citation.rcsb%5Fauthors:Leblanc, Y.), [Cote, A.](/search?q=citation.rcsb%5Fauthors:Cote, A.), [Nasveschuk, C.G.](/search?q=citation.rcsb%5Fauthors:Nasveschuk, C.G.), [Taylor, A.M.](/search?q=citation.rcsb%5Fauthors:Taylor, A.M.), [Harmange, J.C.](/search?q=citation.rcsb%5Fauthors:Harmange, J.C.), [Audia, J.E.](/search?q=citation.rcsb%5Fauthors:Audia, J.E.), [Pardo, E.](/search?q=citation.rcsb%5Fauthors:Pardo, E.), [Joshi, S.](/search?q=citation.rcsb%5Fauthors:Joshi, S.), [Sandy, P.](/search?q=citation.rcsb%5Fauthors:Sandy, P.), [Mertz, J.A.](/search?q=citation.rcsb%5Fauthors:Mertz, J.A.), [Sims, R.J.](/search?q=citation.rcsb%5Fauthors:Sims, R.J.), [Bergeron, L.](/search?q=citation.rcsb%5Fauthors:Bergeron, L.), [Bryant, B.M.](/search?q=citation.rcsb%5Fauthors:Bryant, B.M.), [Bellon, S.](/search?q=citation.rcsb%5Fauthors:Bellon, S.), [Poy, F.](/search?q=citation.rcsb%5Fauthors:Poy, F.), [Jayaram, H.](/search?q=citation.rcsb%5Fauthors:Jayaram, H.), [Sankaranarayanan, R.](/search?q=citation.rcsb%5Fauthors:Sankaranarayanan, R.), [Yellapantula, S.](/search?q=citation.rcsb%5Fauthors:Yellapantula, S.), [Bangalore Srinivasamurthy, N.](/search?q=citation.rcsb%5Fauthors:Bangalore Srinivasamurthy, N.), [Birudukota, S.](/search?q=citation.rcsb%5Fauthors:Birudukota, S.), [Albrecht, B.K.](/search?q=citation.rcsb%5Fauthors:Albrecht, B.K.)
(2013) ACS Med Chem Lett 4: 835-840
PubMed Abstract:
The identification of a novel series of small molecule BET inhibitors is described. Using crystallographic binding modes of an amino-isoxazole fragment and known BET inhibitors, a structure-based drug design effort lead to a novel isoxazole azepine scaffold. This scaffold showed good potency in biochemical and cellular assays and oral activity in an in vivo model of BET inhibition.
Organizational Affiliation:
Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.